share_log

Applied Therapeutics Says FDA Unable To Approve Govorestat NDA Due To Clinical Deficiencies; Expects To Submit An NDA Early In Q1 Of 2025

Benzinga ·  Nov 28 05:16
Applied Therapeutics Says FDA Unable To Approve Govorestat NDA Due To Clinical Deficiencies; Expects To Submit An NDA Early In Q1 Of 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment